Clinical Trial Update: Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating rosuvastatin to lower circulating tissue factor–bearing microparticles in metastatic breast cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05